» Articles » PMID: 24298313

Building a Tissue in Vitro from the Bottom Up: Implications in Regenerative Medicine

Overview
Date 2013 Dec 4
PMID 24298313
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue engineering aims at creating biological tissues to improve or restore the function of diseased or damaged tissues. To enhance the performance of engineered tissues, it is required to recapitulate in vitro not only the composition but also the structural organization of native tissues. To this end, tissue engineering techniques are beginning to focus on generating micron-sized tissue modules having specific microarchitectural features that can be used alone as living filler in the damaged areas or serve as building blocks to engineer large biological tissues by a bottom-up approach. This work discusses the shortcomings related to traditional "top-down" strategies and the promises of emerging ''bottom-up" approaches in creating engineered biological tissues. We first present an overview of the current tissue-building techniques and their applications, with an analysis of the potentiality and shortcomings of different approaches. We then propose and discuss a novel method for the biofabrication of connective-like micro tissues and how this technique can be translated to cardiac muscle fabrication.

Citing Articles

Hollow pollen grains as scaffolding building blocks in bone tissue engineering.

Zakhireh S, Barar J, Beygi-Khosrowshahi Y, Barzegari A, Omidi Y, Adibkia K Bioimpacts. 2022; 12(3):183-193.

PMID: 35677670 PMC: 9124872. DOI: 10.34172/bi.2021.24.


Modular Orthopaedic Tissue Engineering With Implantable Microcarriers and Canine Adipose-Derived Mesenchymal Stromal Cells.

Simitzi C, Vlahovic M, Georgiou A, Keskin-Erdogan Z, Miller J, Day R Front Bioeng Biotechnol. 2020; 8:816.

PMID: 32775324 PMC: 7388765. DOI: 10.3389/fbioe.2020.00816.


Intrinsic Abnormalities of Cystic Fibrosis Airway Connective Tissue Revealed by an In Vitro 3D Stromal Model.

Mazio C, Scognamiglio L, De Cegli R, Galietta L, di Bernardo D, Casale C Cells. 2020; 9(6).

PMID: 32492951 PMC: 7348935. DOI: 10.3390/cells9061371.


Ciprofloxacin-Modified Degradable Hybrid Polyurethane-Polylactide Porous Scaffolds Developed for Potential Use as an Antibacterial Scaffold for Regeneration of Skin.

Iga C, Agata T, Marcin L, Natalia F, Justyna K Polymers (Basel). 2020; 12(1).

PMID: 31936529 PMC: 7022267. DOI: 10.3390/polym12010171.


Bioengineered Skin Substitutes: the Role of Extracellular Matrix and Vascularization in the Healing of Deep Wounds.

Urciuolo F, Casale C, Imparato G, Netti P J Clin Med. 2019; 8(12).

PMID: 31805652 PMC: 6947552. DOI: 10.3390/jcm8122083.


References
1.
Caplan A, Elyaderani M, Mochizuki Y, Wakitani S, Goldberg V . Principles of cartilage repair and regeneration. Clin Orthop Relat Res. 1997; (342):254-69. View

2.
Naito H, Melnychenko I, Didie M, Schneiderbanger K, Schubert P, Rosenkranz S . Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation. 2006; 114(1 Suppl):I72-8. DOI: 10.1161/CIRCULATIONAHA.105.001560. View

3.
Du Y, Lo E, Ali S, Khademhosseini A . Directed assembly of cell-laden microgels for fabrication of 3D tissue constructs. Proc Natl Acad Sci U S A. 2008; 105(28):9522-7. PMC: 2474514. DOI: 10.1073/pnas.0801866105. View

4.
Rivron N, Rouwkema J, Truckenmuller R, Karperien M, de Boer J, van Blitterswijk C . Tissue assembly and organization: developmental mechanisms in microfabricated tissues. Biomaterials. 2009; 30(28):4851-8. DOI: 10.1016/j.biomaterials.2009.06.037. View

5.
Zimmermann W, Melnychenko I, Wasmeier G, Didie M, Naito H, Nixdorff U . Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med. 2006; 12(4):452-8. DOI: 10.1038/nm1394. View